States are taking their own steps to lower drug costs; The Wegovy shortage is part of a much bigger problem with weight loss drugs

Taking stock of the drug industry, from the lab to the medicine chest

October 11, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs Medicare may plan to negotiate drug prices, but some states, not content to wait, are moving aggressively to slash costs for their residents. By Ed Silverman Opinion: Listen: The Wegovy shortage is part of a much bigger problem with weight loss drugs The shortage of GLP-1 weight loss drugs like Wegovy is part of a much broader access problem with obesity medicines. By Torie Bosch STAT+ | CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer Care Access issued a statement saying the FDA did not find any issues with its clinical trial procedures, despite accusations made by Pfizer. By Ed Silverman Adobe Major biomedical research funder Wellcome Trust names Røttingen as its new CEO The Norwegian researcher and doctor will take the helm of the second largest private funder of biomedical research in the world. By Andrew Joseph STAT+ | 'Like playing the lottery': A mixed picture for laid-off life sciences workers in Massachusetts Some have bounced back with new jobs, while others have found competition very stiff for positions in the area's biotech industry, The Boston Globe reports. By Jonathan Saltzman — Boston Globe

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser